Stephanie A. Mullane

1.5k total citations
43 papers, 785 citations indexed

About

Stephanie A. Mullane is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Stephanie A. Mullane has authored 43 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 18 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Stephanie A. Mullane's work include Bladder and Urothelial Cancer Treatments (31 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Urinary and Genital Oncology Studies (10 papers). Stephanie A. Mullane is often cited by papers focused on Bladder and Urothelial Cancer Treatments (31 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Urinary and Genital Oncology Studies (10 papers). Stephanie A. Mullane collaborates with scholars based in United States, Italy and Canada. Stephanie A. Mullane's co-authors include Joaquim Bellmunt, Toni K. Choueiri, Lillian Werner, Jeffrey J. Leow, André P. Fay, Sabina Signoretti, Gordon J. Freeman, Marcella Callea, F. Stephen Hodi and Mary Ellen Taplin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Stephanie A. Mullane

42 papers receiving 778 citations

Peers

Countries citing papers authored by Stephanie A. Mullane

Since Specialization

Citations

This map shows the geographic impact of Stephanie A. Mullane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie A. Mullane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie A. Mullane more than expected).

Fields of papers citing papers by Stephanie A. Mullane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie A. Mullane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie A. Mullane. The network helps show where Stephanie A. Mullane may publish in the future.

Co-authorship network of co-authors of Stephanie A. Mullane

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie A. Mullane. A scholar is included among the top collaborators of Stephanie A. Mullane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie A. Mullane. Stephanie A. Mullane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient‐Centred Web‐Based Information on Head and Neck Squamous Cell Carcinoma: Quality and Readability 2025 ·Oral Diseases ·B.H.E. Jansen, Stephanie A. Mullane, (unknown), Bobby K. Joseph, Mohammed Junaid, Ramesh Balasubramaniam, Agnieszka M. Frydrych, Omar Kujan	0
2	Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy 2018 ·Clinical Genitourinary Cancer ·Guru Sonpavde, Gregory R. Pond, Jonathan E. Rosenberg, Toni K. Choueiri, Joaquim Bellmunt, Ashley Marie Regazzi, Stephanie A. Mullane, Andrea Necchi, Daniele Raggi, Jae‐Lyun Lee, (unknown), Joe Leigh Simpson, Christina Louise Derleth, Shih‐Wen Lin, Dean F. Bajorin	11
3	DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma 2017 ·Clinical Cancer Research ·Min Yuen Teo, Richard Bambury, Emily C. Zabor, Emmet Jordan, Hikmat Al‐Ahmadie, Mariel Elena Boyd, Nancy Bouvier, Stephanie A. Mullane, K. Eugene, Nitin Roper, Irina Ostrovnaya, David M. Hyman, Bernard H. Bochner, Maria E. Arcila, David B. Solit, Michael F. Berger, Dean F. Bajorin, Joaquim Bellmunt, Gopa Iyer, Jonathan E. Rosenberg	189
4	Loss-of-function of PBRM1 to predict response to anti-PD-1/PD-L1 therapy in metastatic renal cell carcinoma. 2017 ·Journal of Clinical Oncology ·Diana Miao, Claire A. Margolis, Dylan J. Martini, Stephanie A. Mullane, Dana Cullen, Christine E. Horak, Megan Wind‐Rotolo, Matthew D. Hellmann, Martin H. Voss, Robert J. Motzer, Craig Norton, Sabina Signoretti, Alexandra Snyder, Eliezer M. Van Allen, Toni K. Choueiri	3
5	Abstract A18: Genomic and neoantigen evolution and resistance to immune checkpoint blockade in metastatic renal cell carcinoma 2017 ·Cancer Immunology Research ·Diana Miao, Guillermo de Velasco, Dennis O. Adeegbe, Craig Norton, Dylan J. Martini, Stephanie A. Mullane, Raphael Brandão Moreira, Sabina Signoretti, Kwok‐Kin Wong, Toni K. Choueiri, Eliezer M. Van Allen	1
6	Cell-free tumor DNA and TERT promoter mutations in bladder cancer. 2017 ·Journal of Clinical Oncology ·Franklin W. Huang, Mikael L. Rinne, (unknown), Stephanie A. Mullane, Irene Moreno, Sarah C. Reed, Greg Gydush, Viktor A. Adalsteinsson, Jesse Novak, William C. Hahn, Sabina Signoretti, Toni K. Choueiri, Levi A. Garraway, Joaquim Bellmunt	1
7	Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma 2016 ·Clinical Genitourinary Cancer ·Guru Sonpavde, Gregory R. Pond, Giuseppe Di Lorenzo, Carlo Buonerba, (unknown), Gaetano Lanzetta, Andrea Necchi, Patrizia Giannatempo, Daniele Raggi, Kazumasa Matsumoto, Toni K. Choueiri, Stephanie A. Mullane, Günter Niegisch, Peter Albers, J.L. Lee, Hiroshi Kitamura, Haruki Kume, Joaquim Bellmunt	1
8	Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy 2016 ·British Journal of Cancer ·Joaquim Bellmunt, Chensheng W. Zhou, Stephanie A. Mullane, Lillian Werner, Mary‐Ellen Taplin, André P. Fay, Toni K. Choueiri, Anna Orsola, David Y. Takeda, William C. Hahn, Jaegil Kim, Guru Sonpavde, Michaela Bowden	8
9	Cancer immunotherapy 2016 ·Current Opinion in Urology ·Stephanie A. Mullane, Joaquim Bellmunt	5
10	Precision medicine for advanced prostate cancer 2016 ·Current Opinion in Urology ·Stephanie A. Mullane, Eliezer M. Van Allen	21
11	Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma 2016 ·Scientific Reports ·Stephanie A. Mullane, Lillian Werner, Jonathan E. Rosenberg, Sabina Signoretti, Marcella Callea, Toni K. Choueiri, Gordon J. Freeman, Joaquim Bellmunt	39
12	Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma 2015 ·Annals of Oncology ·Joaquim Bellmunt, Stephanie A. Mullane, Lillian Werner, André P. Fay, Marcella Callea, Jeffrey J. Leow, Mary Ellen Taplin, Toni K. Choueiri, F. Stephen Hodi, Gordon J. Freeman, Sabina Signoretti	229
13	Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma 2015 ·Clinical Genitourinary Cancer ·Stephanie A. Mullane, Lillian Werner, Elizabeth A. Guancial, Rosina T. Lis, Edward C. Stack, Massimo Loda, Philip W. Kantoff, Toni K. Choueiri, Jacob Rosenberg, Joaquim Bellmunt	31
14	Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma 2015 ·European Urology ·Guru Sonpavde, Gregory R. Pond, Toni K. Choueiri, Stephanie A. Mullane, Günter Niegisch, Peter Albers, Andrea Necchi, Giuseppe Di Lorenzo, Carlo Buonerba, (unknown), Kazumasa Matsumoto, Jae‐Lyun Lee, Hiroshi Kitamura, Haruki Kume, Joaquim Bellmunt	55
15	Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma. 2015 ·Journal of Clinical Oncology ·Richard Bambury, Emmet Jordan, Emily C. Zabor, Nancy Bouvier, Hikmat Al‐Ahmadie, Mariel Elena Boyd, Stephanie A. Mullane, K. Eugene, Irina Ostrovnaya, David M. Hyman, Bernard H. Bochner, Maria E. Arcila, David B. Solit, Dean F. Bajorin, Joaquim Bellmunt, Michael F. Berger, Gopa Iyer, Jonathan E. Rosenberg	3
16	Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010 2015 ·Urologic Oncology Seminars and Original Investigations ·Alexander P. Cole, Deepansh Dalela, Julian Hanske, Stephanie A. Mullane, Toni K. Choueiri, Christian P. Meyer, Paul L. Nguyen, Mani Menon, Adam S. Kibel, Mark A. Preston, Joaquim Bellmunt, Quoc‐Dien Trinh	21
17	Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors 2015 ·PLoS ONE ·Joaquim Bellmunt, Lillian Werner, Jeffrey J. Leow, Stephanie A. Mullane, André P. Fay, Markus Riester, Paul Van Hummelen, Mary‐Ellen Taplin, Toni K. Choueiri, Eliezer M. Van Allen, Jonathan E. Rosenberg	16
18	HER2 as a target in invasive urothelial carcinoma 2015 ·Cancer Medicine ·Joaquim Bellmunt, Lillian Werner, Aristotle Bamias, André P. Fay, Rachel S. Park, Markus Riester, Shamini Selvarajah, Justine A. Barletta, David M. Berman, Silvia de Muga, Marta Salido, Enrique Gallardo, Federico Rojo, Elizabeth A. Guancial, Richard Bambury, Stephanie A. Mullane, Toni K. Choueiri, Massimo Loda, Edward C. Stack, Jonathan E. Rosenberg	43
19	Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design 2014 ·Clinical Genitourinary Cancer ·Guru Sonpavde, Gregory R. Pond, Stephanie A. Mullane, Angela Qu, Giuseppe Di Lorenzo, Piera Federico, Andrea Necchi, Jonathan E. Rosenberg, Joaquim Bellmunt, Toni K. Choueiri	5
20	Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients 2014 ·British Journal of Cancer ·Anna Orsola, Lillian Werner, Inés de Torres, William Martin‐Doyle, Carles X. Raventós, Fernando Lozano, Stephanie A. Mullane, Jeffrey J. Leow, Justine A. Barletta, Joaquim Bellmunt, Juan Moróte	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact